Company search
Overview
Performance
Portfolio
ESG
Dividends
Charges
Gearing
Research
Announcements
Management
Documents
Invest
Engage
Data as at: 17/04/2024
In
Objective
To provide Shareholders with capital growth and income over the long term, through investment in listed or quoted global healthcare companies.
AIC sector
Management group
Bellevue Asset Management
Company website
Launch date
02/12/2016
November
Domicile
United Kingdom
Fund manager
Paul Major, Brett Darke
Dividend frequency
Semi-Annually
Wind-up provisions
There are no specific provisions for the termination of the life of the Company.
| Market Cap (m) | Total assets (m) | Price (last close) | NAV | Discount / premium (%) | Gearing (%) | Dividend yield (%) | Dividend dates | Ongoing charge (%) |
|---|---|---|---|---|---|---|---|---|
| 654.60 | 737.83 | 141.60 | 152.65 | -7.24 | 0 | 3.56 | Feb, Jul | 1.02 (30/11/2023) |
Scroll
Dividends
Dividends declared in last 12 months
| Ex-Dividend date | Payment date | Dividend amount | Special dividend | Financial year |
|---|---|---|---|---|
| 09/05/2024 | 31/05/2024 | 2.995 | No | 2023 |
| 27/07/2023 | 25/08/2023 | 2.995 | No | 2023 |
Scroll
Performance (%)
| Return type | 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|---|
| Bellevue Healthcare Trust | Share price total return | -7.7 | -22.8 | 24.9 | N/A |
| Biotechnology & Healthcare AIC sector | Share price total return | -1.1 | -22.2 | 1.6 | 132.9 |
Scroll
Share structure
Number of shares
462,288,550
16,698,646
Traded volumes (number of shares)
| Yesterday | 1 month | 1 year | 5 years | |
|---|---|---|---|---|
| Total | 1,107,229 | 43,029,352 | 306,945,274 | 1,338,647,145 |
| Average | N/A | 2,101,740 | 1,213,370 | 1,062,490 |
Scroll
Traded values (m)
| Yesterday | 1 month | 1 year | 5 years | |
|---|---|---|---|---|
| Total | 1.57 | 64.32 | 445.91 | 2,153.18 |
| Average | N/A | 3.14 | 1.76 | 1.71 |
Scroll
Trading details
Top holdings
Data as at : 30/11/2023
| Investment | % of total assets |
|---|---|
| Option Care Health Inc | 6.9 |
| Insmed Inc | 6.9 |
| Axonics Inc | 6.9 |
| Evolent Health Inc Class A | 6.6 |
| Exact Sciences Corp | 6.4 |
| Intuitive Surgical Inc | 5.2 |
| Pacific Biosciences of California Inc | 5.1 |
| Apellis Pharmaceuticals Inc | 4.8 |
| Bio-Rad Laboratories Inc Class A | 4.8 |
| Charles River Laboratories International Inc | 4.8 |
Data provided by Morningstar.
Company documents provided by FE fundinfo.
